The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults
Commercially relevant palmitic acid-rich IE fats consumed at 10% energy for a 6-wk period do not adversely affect total:HDL cholesterol ratio or other CMD risk markers compared with stearic acid-rich fats. Long-term effects could not be determined from this trial. This trial was registered at clinicaltrials.gov as NCT04418102.
Authors
- Wendy Louise Hall (ORCID: https://orcid.org/0000-0003-1634-6930)
- Tyler Maher (ORCID: https://orcid.org/0000-0001-6604-1719)
- Harry Smith (ORCID: https://orcid.org/0000-0003-1020-1837)
- Sarah Berry (ORCID: https://orcid.org/0000-0002-5819-5109)
- Alice Creedon (ORCID: https://orcid.org/0000-0001-5054-1786)
- Peter J. Joris (ORCID: https://orcid.org/0000-0001-6852-5776)
- Ronald P. Mensink
- Johanna Bruce (ORCID: https://orcid.org/0000-0002-7481-7377)
- Eleanor Wood
Institutions
- King's College London (GB)
- Bexley College (GB)
- Maastricht University (NL)
- Erith and District Hospital (GB)
- Nutrition Sciences (Belgium) (BE)
- University of Bath (GB)
Publication Details
- Journal
- American Journal of Clinical Nutrition
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1016/j.ajcnut.2025.09.025
- Citations
- 1
- Primary Topic
- Fatty Acid Research and Health
- Type
- article
- Field-Weighted Citation Impact
- 1.12